-
-
-
-
-
-
-
HOOKIPA Pharma Announces Pricing of $75.0 Million Public Offering of Common Stock and Non-Voting Convertible Preferred Stock
-
-
-
-
-
-
-
HOOKIPA Pharma Announces Closing of Public Offering of $80.9 Million of Common Stock and Preferred Stock, Including Full Exercise of Underwriters’ Option
-
-
-
-
-
-
-
Form S-3 HOOKIPA Pharma Inc.
70,557 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

